-
公开(公告)号:US20250059155A1
公开(公告)日:2025-02-20
申请号:US18776585
申请日:2024-07-18
Applicant: Genentech, Inc. , Hoffmann-La Roche Inc.
Inventor: Rene LEBL , Ngiap Kie LIM , Roland Christoph MEIER , Ugo Jonathan ORCEL , Joerg SEDELMEIER , Jeff SHEN , Lauren Elizabeth SIROIS , Jacob C. TIMMERMAN , Etienne TRACHSEL , Nicholas Andrew WHITE , Jie XU , Haiming ZHANG , Stephan BACHMANN , Thomas Michael BASS , Raphael BIGLER , Johannes Adrian BURKHARD , Kyle Bradley Pascual CLAGG , Francis GOSSELIN , Chong HAN , Dainis KALDRE , Sean M. KELLY , Sebastian HEROLD , Christian LEITNER
IPC: C07D401/04 , B01J23/44 , B01J23/755
Abstract: Provided herein are methods to synthesize compounds useful in the treatment of cancer where such compounds comprise a quinazolinyl core moiety and at least one stereoisomeric or atropisomeric moiety.
-
公开(公告)号:US20240034739A1
公开(公告)日:2024-02-01
申请号:US18479596
申请日:2023-10-02
Applicant: Genentech, Inc. , Hoffmann-La Roche Inc.
Inventor: Allen Yu HONG , Nicholas WONG , Sean M. KELLY , Lauren Elizabeth SIROIS , Sara SCHWEGLER , Xin LINGHU , Francis GOSSELIN , Katarzyna Aleksandra PIECHOWICZ , Carmela MOLINARO , Dennis WETZL
IPC: C07D487/04 , C12P7/62 , C07D207/273
CPC classification number: C07D487/04 , C12P7/62 , C07D207/273
Abstract: Processes are provided herein for the preparation of a bicyclic ketone compound of formula (I), or a stereoisomer thereof:
or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3 and n are as defined herein; and compounds prepared by these processes.-
公开(公告)号:US20230250074A1
公开(公告)日:2023-08-10
申请号:US18164302
申请日:2023-02-03
Applicant: Genentech, Inc. , Hoffmann-La Roche Inc.
Inventor: Rene LEBL , Ngiap Kie LIM , Roland Christoph MEIER , Ugo Jonathan ORCEL , Joerg SEDELMEIER , Jeff SHEN , Lauren Elizabeth SIROIS , Jacob C. TIMMERMAN , Etienne TRACHSEL , Nicholas Andrew WHITE , Jie XU , Haiming ZHANG , Stephan BACHMANN , Thomas Michael BASS , Raphael BIGLER , Johannes Adrian BURKHARD , Kyle Bradley Pascual CLAGG , Francis GOSSELIN , Chong HAN , Dainis KALDRE , Sean M. KELLY , Sebastian HEROLD , Christian LEITNER
IPC: C07D401/04 , B01J23/44 , B01J23/755
CPC classification number: C07D401/04 , B01J23/44 , B01J23/755
Abstract: Provided herein are methods to synthesize compounds useful in the treatment of cancer where such compounds comprise a quinazolinyl core moiety and at least one stereoisomeric or atropisomeric moiety.
-
公开(公告)号:US20190292201A1
公开(公告)日:2019-09-26
申请号:US16441765
申请日:2019-06-14
Applicant: Genentech, Inc.
Inventor: Francis GOSSELIN , Chong HAN , Theresa CRAVILLION , Sean M. KELLY , Scott SAVAGE
IPC: C07D498/04
Abstract: Methods of making benzoxazepin oxazolidinone compounds as well as synthetic intermediates are described, including compound 18, having the structure:
-
-
-